- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-07-0011388

DRV Pharmaceuticals Private Limited
About DRV Pharmaceuticals Private Limited
Data last updated:
DRV Pharmaceuticals Private Limited is a private limited company based in Kottayam, Kerala, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24299KL2018PTC054399.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dinesh Santhakumari (Managing Director) and Kombanal Ittoop Robins.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kottayam, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹94.68 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹3.54 Lakh (net margin 3.7%) and EBITDA of ₹5.51 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 62% over five years.
DRV Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-07-0011388).
Recognitions & Rankings of DRV Pharmaceuticals
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address7/1160 Surya Building, S H Mount P.O, Kottayam, Kerala, India – 686006
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of DRV Pharmaceuticals Private Limited
The main business activity of DRV Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of DRV Pharmaceuticals Private Limited FY 2025 filings available
DRV Pharmaceuticals Private Limited reported revenue of ₹94.68 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of DRV Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 62% over five years, including 25% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DRV Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.51 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.54 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of DRV Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DRV Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of DRV Pharmaceuticals Private Limited
DRV Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Govinda Pai | Additional Director | 25 Sep 2018 | 8 Years 0 Months | Current |
| Dinesh Santhakumari | Managing Director | 24 Aug 2018 | 8 Years 1 Months | Current |
| Kombanal Ittoop Robins Also directs: Beberry Care Private Limited | Director | 17 Mar 2022 | 4 Years 7 Months | Current |
Peer Comparison of DRV Pharmaceuticals Private Limited
DRV Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zentum Pharmaceuticals Private Limited | ₹95.1 Lakh (FY 2024) | •••• | •••• | -7.0% | •••• | Chennai, Tamil Nadu, India |
| Charissa Psion Pharmaceuticals Private Limited | ₹95.08 Lakh (FY 2018) | •••• | •••• | -25.0% | •••• | Chennai, Tamil Nadu, India |
| Barnet Pharmaceuticals Private Limited | ₹95.07 Lakh (FY 2025) | •••• | •••• | 40.0% | •••• | New Delhi, Delhi, India |
| Trivet Pharmaceuticals Private Limited | ₹94.96 Lakh (FY 2024) | •••• | •••• | -7.0% | •••• | Karnal, Haryana, India |
| Orbit Chem Pharmaceuticals Private Limited | ₹94.95 Lakh (FY 2024) | •••• | •••• | -51.0% | •••• | Cherapalli, Telangana, India |
| DRV Pharmaceuticals Private Limited this company | ₹94.68 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | Kottayam, Kerala, India |
| Jacsims Pharmaceuticals Private Limited | ₹94.34 Lakh (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| NBM Pharmaceuticals Private Limited | ₹94.22 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Jodhpur, Rajasthan, India |
| Teq Pharmaceuticals Private Limited | ₹94.02 Lakh (FY 2018) | •••• | •••• | 346.0% | •••• | Thane, Maharashtra, India |
| Ibc Pharmaceuticals Private Limited | ₹94 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Thane, Maharashtra, India |
| Gifs Plus Pharmaceuticals Private Limited | ₹93.7 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Washim, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below DRV Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of DRV Pharmaceuticals Private Limited
DRV Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at DRV Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to DRV Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on DRV Pharmaceuticals Private Limited
DRV Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Kombanal Ittoop Robins was appointed as Director on 17 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts for DRV Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DRV Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DRV Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DRV Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DRV Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DRV Pharmaceuticals Private Limited
DRV Pharmaceuticals is an active private limited company based in Kottayam, Kerala, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 24 August 2018 (8+ years old) and is registered under CIN U24299KL2018PTC054399.
DRV Pharmaceuticals reported revenue of ₹94.68 Lakh for FY 2025 (up 25% YoY).
DRV Pharmaceuticals has 3 current directors:
- Dinesh Santhakumari - Managing Director
- Rajesh Govinda Pai - Additional Director
- Kombanal Ittoop Robins - Director
DRV Pharmaceuticals reported a net profit of ₹3.54 Lakh (net margin 3.7%) and EBITDA of ₹5.51 Lakh (EBITDA margin 5.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of DRV Pharmaceuticals is 46% over three years and 62% over five years. In the latest year (FY 2025) revenue rose 25%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of DRV Pharmaceuticals is U24299KL2018PTC054399. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DRV Pharmaceuticals was incorporated on 24 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of DRV Pharmaceuticals by revenue are Zentum Pharmaceuticals Private Limited, Charissa Psion Pharmaceuticals Private Limited, Barnet Pharmaceuticals Private Limited, Trivet Pharmaceuticals Private Limited, Orbit Chem Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kombanal Ittoop Robins was appointed as Director on 17 Mar 2022. Raju Varapuzha Lukose ceased to be Additional Director on 21 Jan 2022. Vinoy George ceased to be Whole-Time Director on 02 Dec 2019. DRV Pharmaceuticals has 5 board changes on record in total.
Yes, DRV Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-07-0011388).
The registered office of DRV Pharmaceuticals is at 71160 Surya Building, S H Mount P.O, Kottayam, Kerala, India – 686006.